Protagen this week appointed Theodor Dingermann to its supervisory board. Dingermann is managing director of the Institute for Pharmaceutical Biology at the Johann Wolfgang Goethe-University. His appointment fills the sixth position on Protagen’s board as required by German law. Dingermann is also on the supervisory board of Innovectis.
Theodor Dingermann
Premium
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.